Covaxin 50 pc effective against symptomatic COVID: Lancet study
Nov 24, 2021
New Delhi [India], November 24 : Two doses of COVID-19 vaccine Covaxin (BBV152) are 50 per cent effective against symptomatic COVID-19 disease, according to the first real-world assessment of the COVID-19 vaccine published in the Lancet Infectious Diseases journal.